Skip to main content

Month: July 2021

EXEL Industries: Number of shares and voting rights 30.06.2021

   EXEL Industries A French public limited company (Société Anonyme) with a share capital of €16,969,750 Registered office:– France Reims Companies Register (RCS): No. B 095 550 356       Disclosure of the number of shares and voting rights comprising the share capital          Date Total number of shares comprising the share capital Total number of voting rightsJune, 30, 2021 6 787 900 Total gross voting rights : 10 855 165Total net* voting rights : 10 608 956  * Total net amount = total amount of voting rights attached to the total number of shares minus those shares that do not carry voting rights (treasury shares).                          2.13.0.0AttachmentEXEL Industries Droits de vote 30.06.2021 EN

Continue reading

Half-year statement and information about the number of executed transactions and the exchanged volume regarding the liquidity agreement of Societe Generale

PRESS RELEASE REGULATED INFORMATION Paris, 07 July 2021 Half-year statement and information about the number of executed transactions and the exchanged volume regarding the liquidity agreement of SOCIETE GENERALE Under the liquidity agreement signed between Société Générale and Rothschild Martin Maurel, the following assets were held by the liquidity account as of 30 June 2021:33,500 shares 3,933,126.00 €As a reminder, on the last half-year liquidity contract statement as of 31 December 2020, the following assets were allocated to the liquidity account:33 500 shares 3,943,192.00 €No transaction has been executed on purchases and sales from 1st January to 30th June 2021 within the framework of the liquidity agreement signed between Société Générale and Rothschild Martin Maurel.          Press contacts: Jean-Baptiste Froville_+33...

Continue reading

VINCI Construction is awarded the contract for works package 2 on the Lyon–Turin rail line

Rueil Malmaison, 7 July 2021 VINCI Construction is awarded the contract for works package 2 on the Lyon–Turin rail lineA €1.43 billion contract covering construction of 46 km of tunnels between Saint-Martin-la-Porte and Modane, in Savoie (France) Over 5 years of workAs part of the construction of the 57.5 km tunnel that will connect Saint-Jean-de-Maurienne (France) and Susa (Italy), the owner Tunnel Euralpin Lyon-Turin (TELT) has awarded the contract for works package 2 to a consortium* led by VINCI Construction Grands Projets. This €1.43 billion contract covers a 23 km section of twin tube tunnel between Saint-Martin-la-Porte and Modane, in Savoie (France). The works involve digging 25 km of tunnel using three tunnel boring machines and 21 km of tunnel using conventional methods, and creating 71 safety tunnels and several galleries....

Continue reading

ASM EXPANDS ITS EPITAXY PRODUCT OFFERINGS WITH NEW INTREPID® ESA™

  Almere, The NetherlandsJuly 7, 2021, 5.45 p.m. CET New epitaxy tool addresses 300mm applications for power, analog and wafer markets ASM International N.V. (Euronext Amsterdam: ASM) today introduced its Intrepid® ESA™ epitaxy tool for 300mm applications for power and analog devices, and for epitaxial silicon wafers. Based on the proven, high-volume-manufacturing Intrepid platform, the new ESA tool expands ASM’s atmospheric epi offerings with ASM’s first 300mm atmospheric cluster tool. The Intrepid ESA offers best-in-class on-wafer performance. An expanding range of semiconductors are needed for 5G smartphones, internet of things (IoT), edge computing, automotive, sensors, renewable energy, and much more. ASM’s epitaxy tools are critical for depositing silicon-based films in diverse, fast growing applications for analog and power devices,...

Continue reading

Disclosure of total number of voting rights and number of shares forming the capital as of June 30, 2021

FOR IMMEDIATE RELEASE         Disclosure of total number of voting rights and number of shares forming the capital as of June 30, 2021 Clichy, France – 07 July 2021 Article L 233-8-II of the French “Code de Commerce” and Article 223-16 of the General Regulations of the French “Autorité des Marchés Financiers”. As of June 30, 2021, the total number of issued shares of SOCIÉTÉ BIC is 45,395,857 shares, representing:66,774,710 voting rights, 66,255,030 voting rights excluding shares without voting rightsABOUT BIC A world leader in stationery, lighters and shavers, BIC brings simplicity and joy to everyday life. For more than 75 years, the Company has honored the tradition of providing high-quality, affordable, essential products to consumers everywhere. Through this unwavering dedication, BIC has become one of the most recognized brands...

Continue reading

Valneva Awarded FDA Breakthrough Designation for its Single-Shot Chikungunya Vaccine Candidate

This new U.S. Milestone Follows FDA Fast Track and EMA PRIME Designations Saint Herblain (France), July 7, 2021 – Valneva SE (“Valneva” or “the Company”), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, today announced that it has been awarded Breakthrough Therapy Designation for its single-shot chikungunya vaccine candidate, VLA1553, by the U.S. Food and Drug Administration (FDA). Breakthrough Therapy Designation intends to facilitate and expedite development and review of new drugs for serious or life-threatening conditions where preliminary clinical data demonstrates that the drug may have substantial improvement for at least one endpoint over available therapies1. This new U.S. milestone comes in addition to the FDA Fast...

Continue reading

Disclosure of Trading in Own Shares for June 2021  

FOR IMMEDIATE RELEASE         Disclosure Of Trading In Own SharesFor June 2021 CLICHY – July 07, 2021 In compliance with general regulation on share buy-backs, SOCIÉTÉ BIC declares below the transactions made on its own shares for June 2021 :Date Number of shares Average weighted price in € Amount in €01/06/21 3 240 60,2008 195 050,5902/06/21 3 240 60,6689 196 567,2403/06/21 3 240 59,7748 193 670,3504/06/21 3 240 60,8562 197 174,0907/06/21 3 200 61,2146 195 886,7208/06/21 3 300 59,7718 197 246,9409/06/21 3 300 59,4282 196 113,0610/06/21 3 300 59,5791 196 611,0311/06/21 3 315 59,2726 196 488,6714/06/21 3 300 59,2211 195 429,6315/06/21 3 335 58,9251 196 515,2116/06/21 3 340 58,9471 196 883,3117/06/21 3 335 58,9628 196 640,9418/06/21 3 263 59,0084 192 544,4121/06/21 3 340 59,0342 197 174,2322/06/21 3...

Continue reading

Sogeclair: voting rights as at 2021/06/30

SOGECLAIRBusiness corporation with a capital of 3 204 901 EurosHead Office: 7 avenue Albert Durand – 31700 BLAGNAC (France)Tel.: +33 (0)5.61.71.71.71 – www.sogeclair.com335 218 269 R.C.S. TOULOUSE Information concerning the total number of voting rights and shares in the share capitalSection L.233-8 II of French commercial law (“Code de commerce”) and section 223-16 of the general rules of the French Financial Markets Authority (‘“Règlement général de l’Autorité des Marchés Financiers”)DATE Total number of shares in the share capital Total number of voting rights30 June 2021 3,204,901 Total voting rights – brut: 5,157,368    Total voting rights – net*: 5,013,530* net total: total number of voting rights attached to the total number of shares –  shares deprived of voting rights (treasury stock etc.)Attachment...

Continue reading

Safe announces its revenues for the first half of 2021

Revenues of €1.085M in Q2 2021, up 67%, despite the impact of the health crisis Revenues of €2.168M in the first half of 2021, up 25%, despite the impact of the health crisis Significant recovery of activity in all markets from the second quarter of 2021.Éragny-sur-Oise, France, July 7th, 2021 at 5:35 p.m. CET – Safe Orthopaedics (FR0013467123 – ALSAF), a company specialising in the design, manufacture and marketing of ready-to-use technologies for back surgery, with a particular focus on the safety of emergency vertebral fractures, announces today its half-yearly revenues for the period ending June 30, 2021. “The Safe Group closes the first half of 2021 with an overall half-year sales growth of 25% compared to the first half of 2020 driven by a 67% sales growth in the second quarter, and this in all geographical sectors in which...

Continue reading

TELUS and Cool Aid bring innovative Health for Good™ mobile health clinic to Victoria

The Cool Aid Mobile Health Clinic, powered by TELUS Health, is a specially-equipped mobile van providing primary healthcare to marginalized people in the Capital regionCool Aid Mobile Health Clinic Powered by TELUSA photo of the Cool Aid Health Clinic powered by TELUS Health. Photo Credit: Karen Mackenrot, TELUSVICTORIA, British Columbia, July 07, 2021 (GLOBE NEWSWIRE) — Today, TELUS and the Victoria Cool Aid Society announced a new partnership through TELUS’ innovative mobile Health for Good program that will bring primary care to underserved people in the Victoria area. According to a 2020 survey1 studying Victoria’s homelessness and housing needs, over 1,500 individuals experience homelessness in Greater Victoria on any given night. These individuals face additional barriers outside of homelessness and are...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.